Aldactone - Spironolactone
5 customer reviewsAldactone is an oral tablet of spironolactone for adults with high blood pressure or fluid retention. It helps the body remove sodium and water while keeping potassium. This makes it a potassium-sparing diuretic.
What is it?
Aldactone is a brand name for spironolactone, a diuretic used in cardiology, nephrology, and hepatology to manage fluid overload and selected blood-pressure cases. Clinically, it’s most familiar as a “potassium-sparing” water tablet, meaning it reduces fluid without driving potassium down the way many other diuretics can. This difference is also why prescribers treat Aldactone with more respect around blood tests and drug interactions.
Composition
Aldactone is an oral tablet containing spironolactone, a potassium-sparing diuretic (aldosterone antagonist).
How to use?
Take Aldactone by mouth as tablets.
- Typical dose: 25 mg to 100 mg per day, adjusted to the condition being treated.
- Frequency: once daily or divided into 2 doses per day.
- Timing: take with food or after meals to reduce stomach upset; if taken once daily, take it at the same time each day, preferably earlier in the day.
- Duration: use for as long as prescribed; your dose may be changed based on response and blood test results.
- Route: oral.
How does it work?
Take Aldactone by mouth as tablets.
- Typical dose: 25 mg to 200 mg per day, depending on the indication and response.
- Frequency: once daily or in 2 divided doses per day.
- Timing: take with food or after meals; if prescribed once daily, take it in the morning or early afternoon to limit nighttime urination.
- Duration: continue for the prescribed treatment period, with dose adjustments based on blood pressure, swelling, and potassium levels.
- Route: oral.
Indications
Aldactone is prescribed when aldosterone-driven salt and water retention is part of the problem, or when clinicians need a diuretic that does not waste potassium.
Common uses include:
- Hypertension (high blood pressure): often as part of an antihypertensive regimen when other medicines do not achieve target pressure or when aldosterone excess is suspected.
- Heart failure: used to help control fluid status and, in selected patients, improve outcomes linked to aldosterone blockade.
- Liver cirrhosis with ascites: helps reduce abdominal fluid accumulation (ascites) by shifting salt and water balance.
- Nephrotic syndrome: supports oedema control when protein loss from the kidneys drives fluid retention.
- Primary hyperaldosteronism (Conn’s syndrome): used for symptom control and potassium normalisation when aldosterone is excessive.
This is also one of the few diuretics with relevant anti-androgen activity, so dermatologists and gynaecologists sometimes use spironolactone off-label for acne or hirsutism in women when androgen sensitivity is a key driver.
Comparison
Aldactone sits in a different niche from thiazide and loop diuretics because it targets aldosterone and tends to conserve potassium. It also behaves differently in timelines: loop diuretics often feel fast and strong for oedema, while spironolactone’s benefit is often steadier and tied to the hormonal driver.
| Option | Key difference | Potassium effect |
|---|---|---|
| Aldactone (spironolactone) | Aldosterone (mineralocorticoid) receptor blocker; useful in heart failure, ascites, hyperaldosteronism | Raises potassium risk |
| Thiazide diuretics | Common for hypertension; weaker diuresis than loops | Lowers potassium risk |
| Loop diuretics | Strong diuresis for significant fluid overload | Lowers potassium risk |
Where clinicians often draw the line: if a patient already runs high potassium or has fragile kidney function, Aldactone may be avoided even if swelling is present. If potassium tends to run low on a loop or thiazide, spironolactone can be a strategic add-on with monitoring rather than just increasing the dose of a potassium-wasting diuretic.
Contraindications
- Hyperkalaemia (high potassium).
- Acute renal failure or significantly impaired kidney function where potassium clearance is reduced.
- Addison’s disease (adrenal insufficiency with low aldosterone).
- A known allergy or hypersensitivity to spironolactone.
- Pregnancy or breastfeeding unless your prescriber has made a clear risk–benefit decision for your situation.
- ACE inhibitors / ARBs / aliskiren: combining these with Aldactone can raise potassium; clinicians often plan closer monitoring.
- Other potassium-sparing diuretics and potassium supplements: additive hyperkalaemia risk.
- NSAIDs (common pain relievers): can reduce kidney perfusion and blunt diuretic effect while increasing potassium risk in vulnerable patients.
- Lithium: diuretics can raise lithium levels; clinicians typically avoid the combination or monitor very closely.
- Digoxin: spironolactone can complicate digoxin interpretation and electrolyte balance; monitoring is common in heart-failure regimens.
Not recommended for
Aldactone can be a good fit for the right indication, but it is not for people with high potassium, severe kidney impairment, or adrenal insufficiency. It is also a medication where contraindications are not optional.
Side effects
Side effects depend on dose, kidney function, and what else you take.
Common or expected effects:
- Gastrointestinal upset: nausea, loose stools, stomach discomfort, more common early on or when taken without food.
- Dizziness or headache: often related to blood pressure changes or fluid shifts.
- Hyperkalaemia: a key class effect; it’s the side effect clinicians watch most closely.
Hormonal (endocrine) effects can be the deciding factor for many patients:
- Gynecomastia (breast enlargement) and breast tenderness in men can occur and may be dose-related.
- Menstrual irregularities and breast tenderness can occur in women; some also report libido changes.
Rare but urgent signals to treat seriously include fainting, severe weakness, palpitations, or signs of a significant allergic reaction (widespread rash with swelling). These patterns are why many clinicians pair spironolactone with periodic electrolyte and renal checks rather than “set and forget”.
Common mistakes
Mix-ups around potassium are the most frequent and the most avoidable.
Mistakes I see repeatedly:
- Adding potassium supplements “for cramps” without checking whether Aldactone is the cause of the cramps or whether potassium is already high.
- Switching to a potassium-based salt substitute while trying to reduce sodium for blood pressure.
- Using NSAIDs daily for back or knee pain while on spironolactone, then wondering why swelling and blood pressure control worsened.
- Expecting a loop-diuretic style “rush to the bathroom,” then taking extra tablets when the effect feels subtle.
- Ignoring early hormonal side effects (breast tenderness, cycle changes) until they become distressing; dose adjustment or a switch is often easier earlier.
Doctor opinions
Doctors reach for Aldactone when aldosterone biology is working against the patient—fluid retention, resistant hypertension patterns, or heart failure where mineralocorticoid receptor blockade adds outcome value. In cardiology clinics, spironolactone is often described as “small tablet, big monitoring,” because benefits are real but tied to correct patient selection and lab follow-up.
A common prescribing pattern is to start low and titrate based on blood pressure, weight trend, symptoms (breathlessness, ankle swelling), kidney function, and potassium. For ascites from liver cirrhosis, clinicians often combine spironolactone with other diuretics to balance sodium removal with potassium safety, and they adjust based on daily weight changes rather than a single blood pressure reading.
One nuance that surprises people: some patients feel “dry” (thirst, dry mouth) without dramatic urine volume. That can still reflect effective sodium handling shifts, not a failure of the medication.
Frequently asked questions
The diuretic effect can begin within a few days, while blood pressure changes may take longer as sodium balance shifts. For heart failure, the aim is symptom control plus longer-term benefit from aldosterone blockade, so the timeline is weeks rather than days. WHO explains spironolactone’s role as an aldosterone antagonist and diuretic used in conditions linked to fluid retention and hypertension.
No—Aldactone is potassium-sparing, meaning it tends to retain potassium while helping remove sodium and water. This can be helpful if potassium tends to run low on other diuretics, yet it also raises the risk of hyperkalaemia in people with kidney impairment or interacting medicines. EMA safety information for spironolactone highlights potassium monitoring as a core part of safe use.
Yes. Primary hyperaldosteronism (Conn’s syndrome) is one of the classic indications, since the condition is defined by aldosterone excess. Spironolactone blocks aldosterone’s effects, helping correct potassium loss and reduce blood pressure in many patients. Treatment plans are still individual because dosing often depends on labs and symptom response rather than a single fixed dose.
Alcohol can add to dizziness and light-headedness by lowering blood pressure, which may be more noticeable when starting spironolactone or after a dose increase. For people taking Aldactone for heart failure or cirrhosis, alcohol may also worsen the underlying condition and fluid balance goals. A practical approach is to avoid alcohol during the first week of therapy and after dose changes, then reassess tolerance based on symptoms like dizziness or palpitations.
Taking Aldactone with a meal often improves stomach tolerance, which is why many prescribers suggest food-adjacent dosing. Food does not remove the need for potassium awareness, since the potassium effect comes from aldosterone receptor blockade in the kidney. If nausea is a barrier, clinicians often adjust timing or split dosing rather than abandoning spironolactone when it’s clinically indicated.
Front view
Side view
Back view
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (9.4x4.3x0.3 in. or 24x11x0.7 cm) and its contents cannot be seen.
Aldactone — Comparison with alternatives
Aldactone Current Best price
Inspra
Azor
Lisinopril Best rated
Clonidine
Reviews and Experiences
Sources
- U.S. Food and Drug Administration (FDA) (2018). ALDACTONE (spironolactone) tablets — Prescribing Information (label) ↑
- European Society of Cardiology (ESC) (2021). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure ↑
- World Health Organization (WHO) (2023). Spironolactone — WHO Model List of Essential Medicines (section entry and notes) ↑
- European Medicines Agency (EMA) (2023). Spironolactone — Summary of Product Characteristics (SmPC) ↑